Stop obsessing over hitting exactly 10 reps—recent findings reveal that training to failure is the ultimate equalizer for strength and hypertrophy.

From rare cancers caught early to dementia foretold decades in advance, newborn genomic testing raises an unsettling question ...

FDA priority review seeks marstacimab label expansion to ≥6 years with inhibitors and ages 6–11 without inhibitors, addressing populations with limited efficacy from factor replacement and high unmet ...

Sustained interest in small molecules, bispecific antibodies, and genomics got the ball rolling in the biotech deals arena in ...

The result is a screening assessment that aims to identify cancer at a much earlier stage than many existing methods.

Discover how Electroencephalography (EEG) records brain activity to diagnose epilepsy, strokes, and sleep disorders. Learn ...

Achieve Life Sciences is a single-asset microcap centered on cytisinicline, with an accepted NDA and a June 20, 2026, PDUFA.

Debated is the genesis of the first direct-to-consumer (DTC) drug concept in the U.S. Going back to at least 2011, Pfizer’s “unorthodox” ...

Results from a recently published randomized, double-blind, placebo-controlled clinical trial show that supplementation with Brightseed® BioMetaControl, containing the naturally occurring bioactive ...

Low back pain (LBP) is a crucial risk factor for future health decline, affecting quality of life of individuals. Now, researchers have discovered ...

Altimmune, Inc. closed a $75 million direct offering to fund Phase 3 pemvidutide trials for MASH. Learn more about ALT stock ...

The American Heart Association just coined the term a few years ago.